SLC9A9 and neoplasm: Therefore, a combination therapy including Dasatinib, ABT-737 and chemotherapy (consisting of cisplatin and vinorelbine) was applied in a nude mouse xenograft model to test its therapeutic effect on tumor grafts with NHE9-induced CRT resistance.